Who owns INHIBRX INC?
- CUSIP Number: 45720l107
Tip: Access positions for across all investors
Analyze quarterly positions in Inhibrx with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Inhibrx stock
Who bought or sold INHIBRX INC this quarter?
There are no current stakeholders of Inhibrx.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Inhibrx?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BlackRock | Mar 2024 | 2.8M | $96M |
| State Street Corporation | Mar 2024 | 2.4M | $85M |
| Vanguard Group | Mar 2024 | 1.9M | $65M |
| TCG Crossover Management | Mar 2024 | 1.8M | $61M |
| Morgan Stanley | Mar 2024 | 550k | $19M |
| Qube Research & Technologies | Mar 2024 | 543k | $19M |
| Goldman Sachs Group | Mar 2024 | 377k | $13M |
| Northern Trust | Mar 2024 | 308k | $11M |
| Two Sigma Advisers | Mar 2024 | 282k | $9.9M |
| Soleus Capital Management | Mar 2024 | 268k | $9.4M |
| Rafferty Asset Management | Mar 2024 | 202k | $7.1M |
| Russell Investments | Mar 2024 | 190k | $6.7M |
| Platinum Investment Mangement | Mar 2024 | 146k | $5.1M |
| HighTower Advisors | Mar 2024 | 132k | $4.6M |
| Nuveen Asset Management | Mar 2024 | 83k | $2.9M |
| Two Sigma Investments | Mar 2024 | 78k | $2.7M |
| Alliancebernstein | Mar 2024 | 36k | $1.3M |
| Alpine Partners VI | Mar 2024 | 35k | $1.2M |
| ALPS Advisors | Mar 2024 | 33k | $1.2M |
| ProFund Advisors | Mar 2024 | 31k | $1.1M |
| DekaBank Deutsche Girozentrale | Jun 2024 | 26k | $928k |